Atlas Trials

A Bridging Trial to Compare the PK Profile When Glepaglutide is Administered Via Vial/Syringe Versus Autoinjector.

Clinical trial NCT04318743 · COMPLETED

Trial details

NCT number
NCT04318743
Sponsor
Zealand Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2020-03-04
Primary completion
2021-06-10
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.